PMID: 18712083Aug 21, 2008Paper

Noninvasive insulin delivery systems

Biomedit︠s︡inskai︠a︡ khimii︠a︡
D Kh Zubaerova, N I Larionova

Abstract

The review considers commercial insulin formulations. Special attention is paid to the difficulties and strategies of development of alternative hormone delivery systems (buccal, transdermal, intranasal, pulmonary and oral). At the moment there is only one approved formulation of the noninvasive insulin in the world.

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Journal of Biomaterials Applications
Y W Chien, J C Liu
Journal de pharmacie de Belgique
Els Mehuys, Chris Vervaet
Krankenpflege Journal
H P Lipp
The Medical Letter on Drugs and Therapeutics
© 2022 Meta ULC. All rights reserved